Morgan Stanley’s Acadia Pharmaceuticals ACAD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$24.3M Sell
1,093,151
-48,823
-4% -$1.17M ﹤0.01% 2773
2025
Q4
$30.5M Sell
1,141,974
-46,432
-4% -$1.11M ﹤0.01% 2550
2025
Q3
$25.4M Sell
1,188,406
-2,922,841
-71% -$69.1M ﹤0.01% 2663
2025
Q2
$88.7M Sell
4,111,247
-568,936
-12% -$10.6M 0.01% 1418
2025
Q1
$77.7M Sell
4,680,183
-2,616,866
-36% -$47.5M 0.01% 1431
2024
Q4
$134M Buy
7,297,049
+5,621,195
+335% +$90.7M 0.01% 1056
2024
Q3
$25.8M Sell
1,675,854
-715,251
-30% -$11.9M ﹤0.01% 2527
2024
Q2
$38.9M Buy
2,391,105
+928,093
+63% +$15M ﹤0.01% 1983
2024
Q1
$27.1M Sell
1,463,012
-1,260,788
-46% -$31.2M ﹤0.01% 2361
2023
Q4
$85.3M Buy
2,723,800
+867,420
+47% +$20.7M ﹤0.01% 1898
2023
Q3
$38.7M Sell
1,856,380
-1,871,600
-50% -$50.8M ﹤0.01% 1818
2023
Q2
$89.3M Sell
3,727,980
-186,724
-5% -$4.15M 0.01% 1163
2023
Q1
$73.7M Buy
3,914,704
+1,169,966
+43% +$22.3M 0.01% 1249
2022
Q4
$43.7M Sell
2,744,738
-326,375
-11% -$5.1M 0.01% 1616
2022
Q3
$50.2M Sell
3,071,113
-48,959
-2% -$793K 0.01% 1311
2022
Q2
$44M Buy
3,120,072
+2,179,690
+232% +$40.7M 0.01% 1478
2022
Q1
$22.8M Buy
940,382
+277,723
+42% +$6.72M ﹤0.01% 1980
2021
Q4
$15.5M Sell
662,659
-158,584
-19% -$3.19M ﹤0.01% 2444
2021
Q3
$13.6M Sell
821,243
-14,409
-2% -$278K ﹤0.01% 2544
2021
Q2
$20.4M Buy
835,652
+192,602
+30% +$4.35M ﹤0.01% 2125
2021
Q1
$16.6M Buy
643,050
+133,567
+26% +$5.88M ﹤0.01% 2112
2020
Q4
$27.2M Buy
509,483
+23,844
+5% +$1.18M ﹤0.01% 1539
2020
Q3
$20M Buy
485,639
+311,707
+179% +$13.5M ﹤0.01% 1487
2020
Q2
$8.43M Sell
173,932
-7,512
-4% -$361K ﹤0.01% 2124
2020
Q1
$7.67M Sell
181,444
-360,203
-67% -$14.8M ﹤0.01% 2020
2019
Q4
$23.2M Buy
541,647
+235,766
+77% +$10.3M 0.01% 1535
2019
Q3
$11M Buy
305,881
+164,360
+116% +$4.98M ﹤0.01% 2020
2019
Q2
$3.78M Sell
141,521
-21,314
-13% -$544K ﹤0.01% 3215
2019
Q1
$4.37M Sell
162,835
-105,706
-39% -$2.47M ﹤0.01% 2839
2018
Q4
$4.34M Buy
268,541
+8,286
+3% +$161K ﹤0.01% 3059
2018
Q3
$5.4M Sell
260,255
-677,452
-72% -$10.7M ﹤0.01% 3102
2018
Q2
$14.3M Buy
937,707
+480,227
+105% +$8.56M ﹤0.01% 1979
2018
Q1
$10.3M Sell
457,480
-441,234
-49% -$12.2M ﹤0.01% 2313
2017
Q4
$27.1M Buy
898,714
+535,322
+147% +$17.1M 0.01% 1411
2017
Q3
$13.7M Buy
363,392
+146,433
+67% +$4.76M ﹤0.01% 1958
2017
Q2
$6.05M Buy
216,959
+27,712
+15% +$826K ﹤0.01% 2656
2017
Q1
$6.51M Sell
189,247
-2,737
-1% -$96.6K ﹤0.01% 2598
2016
Q4
$5.54M Sell
191,984
-25,696
-12% -$680K ﹤0.01% 2883
2016
Q3
$6.92M Buy
217,680
+51,940
+31% +$1.76M ﹤0.01% 2350
2016
Q2
$5.38M Sell
165,740
-88,558
-35% -$2.96M ﹤0.01% 2546
2016
Q1
$7.11M Sell
254,298
-66,885
-21% -$1.46M ﹤0.01% 2178
2015
Q4
$11.4M Buy
321,183
+27,260
+9% +$960K ﹤0.01% 1856
2015
Q3
$9.72M Buy
293,923
+29,866
+11% +$1.24M ﹤0.01% 1980
2015
Q2
$11.1M Sell
264,057
-26,236
-9% -$1.02M ﹤0.01% 2013
2015
Q1
$9.46M Sell
290,293
-222,042
-43% -$7.63M ﹤0.01% 2106
2014
Q4
$16.3M Buy
512,335
+402,914
+368% +$11.4M 0.01% 1631
2014
Q3
$2.71M Buy
109,421
+30,531
+39% +$714K ﹤0.01% 3186
2014
Q2
$1.78M Sell
78,890
-79,033
-50% -$1.65M ﹤0.01% 3571
2014
Q1
$3.84M Buy
157,923
+61,395
+64% +$1.55M ﹤0.01% 2825
2013
Q4
$2.41M Sell
96,528
-72,778
-43% -$1.72M ﹤0.01% 3247
2013
Q3
$4.65M Buy
169,306
+77,575
+85% +$1.62M ﹤0.01% 2492
2013
Q2
$1.67M Buy
+91,731
New +$1.26M ﹤0.01% 3305

Other funds holding ACAD